Press release
Innovative Angiography Systems Advancing Tumor Embolization Treatments Trend: A Crucial Influence on the Tumor Embolization Devices Market's Transformation in 2025
Tumor Embolization Devices Market Size
In recent times, the market size for tumor embolization devices has experienced significant growth. Projected to increase from a size of $1493.6 billion in 2024 to $1600.57 billion in 2025, it boasts a compound annual growth rate (CAGR) of 7.2%. The growth observed during the historic period can be linked to factors such as minimally invasive procedures, advancements in technology, increased incidence of cancer, and an aging population.
In the upcoming years, the market size for tumor embolization devices is anticipated to experience significant growth. The market is projected to escalate to $2286.1 billion by 2029, with a compound annual growth rate (CAGR) of 9.3%. The growth in the predicted period can be attributed to factors like personalized medicine, combination therapies, image-guided embolization, telemedicine, and remote consultations. Key trends that might be observed in this period will include advancements in embolic agents, transarterial chemoembolization (tace), embolization for palliative care, and image-guided procedures.
What Factors Are Fueling Growth in the Tumor Embolization Devices Market?
The global upsurge in cancer diagnoses is expected to spur the growth of the tumor embolization devices market in the projected timeframe. As an example, Macmillan Cancer Support, the premier healthcare charitable institution in the UK, projected in October 2022 that cancer patients would surge upward to 3.5 million by 2025, then to 4 million by 2030, and eventually hit 5.3 million by 2040. Consequently, this global influx in cancer occurrences is forecasted to stimulate the demand for the tumor embolization market in the upcoming years.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3352&type=smp
Which Leading Companies Are Shaping the Growth of the Tumor Embolization Devices Market?
Major companies operating in the tumor embolization devices market include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc., Cook Medical LLC, AngioDynamics Inc., Siemens Healthineers AG, Johnson & Johnson, Penumbra Inc., Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., Kaneka Corporation, Imagion Biosystems Ltd., Guerbet, BTI Biotechnology Institute S.L., BTG International, Avinger Inc., Shape Memory Medical Inc., Delcath Systems Inc., Endoshape Inc., InSitu Technologies Inc., Monteris Medical Corporation, NeuWave Medical Inc., Neoprobe Corporation, OncoSec Medical Incorporated, Helomics Corporation, Hologic, Surefire Medical Inc., Varian Medical Systems Inc.
What Are the Major Trends Shaping the Tumor Embolization Devices Market?
Leading businesses in the tumor embolization devices market are focusing on product innovation, particularly angiography systems, to enhance the precision and effectiveness of cancer treatment methods. These angiography systems are unique imaging tools that enable visualization of the body's blood vessels and the evaluation of blood flow. For example, in June 2022, a healthcare company from Germany, Siemens Healthineers, unveiled their product called Artis Icono Ceiling. The Artis Icono Ceiling is a ceiling-mounted angiography system developed to increase the accuracy of tumor embolization procedures and other interventional methods. The device provides rapid 3D data collection, with the ability to take images at the patient's head within 2.5 seconds and side views in 4 seconds. This is advantageous as it reduces motion artifacts and lessens the use of contrast media. Furthermore, the Artis Icono Ceiling is constructed for multipurpose use, making it suitable for a variety of disciplines, including interventional radiology and cardiology.
What Are the Key Segments of the Tumor Embolization Devices Market?
The tumor embolization devices market covered in this report is segmented -
1) By Type: Radioembolic Agents, Non-radioactive Embolic Agents
2) By Application: Cancer Tumors, Noncancerous Tumors
3) By End User: Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers
Subsegments:
1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres, Holmium-166 Microspheres
2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs), Microspheres (Polyvinyl Alcohol - PVA Particles), Gelatin Sponges, Liquid Embolic Agents (Onyx, Glue-Based Agents)
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
Which Region Dominates the Tumor Embolization Devices Market?
North America was the largest region in the tumor embolization devices market in 2023. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Is Covered In The Tumor Embolization Devices Global Market Report?
- Market Size Analysis: Analyze the Tumor Embolization Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Tumor Embolization Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Tumor Embolization Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Tumor Embolization Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3352
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Innovative Angiography Systems Advancing Tumor Embolization Treatments Trend: A Crucial Influence on the Tumor Embolization Devices Market's Transformation in 2025 here
News-ID: 3931413 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Tumor
Evolving Market Trends In The Carcinoid Tumor Industry: Advancements In Neuroend …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Expected Carcinoid Tumor Market Size During the Forecast Period?
In recent years, there has been a significant increase in the market size of carcinoid tumors, which is projected to expand from $1.61 billion in 2024 to $1.78 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.7%.…
Brain Tumor Foundation to Present Brain Tumor InfoCon, a Free Informational Prog …
Image: https://www.getnews.info/wp-content/uploads/2024/10/1727733338.jpeg
Brain Tumor Foundation
October 8 online presentations to feature world's leading experts discussing topics ranging from neuro-oncology trials to targeting metabolism in glioblastoma and cytokine microdialysis
NEW YORK - The Brain Tumor Foundation [https://www.braintumorfoundation.org/] (BTF), the nation's premier non-profit dedicated to providing support and guidance for brain tumor patients and their families, today announced that it will be presenting Brain Tumor InfoCon [https://braintumorfoundation.org/resources/2798-2/], a free informational program for patients and caregivers.…
Germ Cell Tumor Market - Revolutionizing Germ Cell Tumor Care: Next-Generation T …
Newark, New Castle, USA: The "Germ Cell Tumor Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Germ Cell Tumor Market: https://www.growthplusreports.com/report/germ-cell-tumor-market/8949
This latest report researches the industry structure,…
Global Wilms Tumor Market
Global Wilms Tumor Market Analysis and Insights
The wilms tumor market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.30% in the above-mentioned research forecast period. Ongoing research and products under clinical trials are the factors for the growth of the wilms tumor market.
Request Access Global Wilms Tumor Market…
Brain Tumor Treatment Market
Brain Tumor Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
The global Brain Tumor Diagnosis and Treatments market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Brain Tumor Diagnosis and Treatments…
Rising Prevalence of brain Tumor Couple with Geriatric Populations supporting gr …
Albany, NY, 26th February : Recent research and the current scenario as well as future market potential of "Brain Tumor Therapeutics: Global Markets to 2023" globally.
ResearchMOZ.us has published a fresh report to its vast repository titled “Global Brain Tumor Therapeutics Market - Segmented by Type of Cancer and Therapeutics - Growth, Trends and Forecasts 2018-2026” to its offerings. The report provides comprehensive analysis of the global tumor therapeutics market in the…
